Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Elizabeth A. Ashley"'
Autor:
Nicholas J. White, Jullien, Andreas Mårtensson, Carol Hopkins Sibley, Steffen Borrmann, Gilbert Lefèvre, Michèle van Vugt, Karen I. Barnes, François Nosten, Christian Nsanzabana, Lars Rombo, Rose McGready, Kamal Hamed, Blaise Genton, Harin Karunajeewa, Francesca T. Aweeka, Philippe J Guerin, Liusheng Huang, Birgit Schramm, Pascal Ringwald, Tme Davis, Johan Ursing, Sunil Parikh, Eva Maria Hodel, Mey Bouth Denis, Prabin Dahal, C Moreira, Mayfong Mayxay, Ric N. Price, Kiechel, Kasia Stepniewska, Paul N. Newton, Lesley Workman, Quique Bassat, Poul-Erik Kofoed, Billy Ngasala, Philippe Deloron, Elizabeth A. Ashley, Niklas Lindegardh, Jean-François Faucher, Kevin Marsh, Abdoulaye Djimde
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Kofoed, P-E & WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group 2015, ' Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria : a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data ', B M C Medicine, vol. 13, 227 . https://doi.org/10.1186/s12916-015-0456-7
BMC medicine, vol. 13, pp. 227
Recercat. Dipósit de la Recerca de Catalunya
instname
BMC Medicine
Universidad de Barcelona
Kofoed, P-E & WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group 2015, ' Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria : a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data ', B M C Medicine, vol. 13, 227 . https://doi.org/10.1186/s12916-015-0456-7
BMC medicine, vol. 13, pp. 227
Recercat. Dipósit de la Recerca de Catalunya
instname
BMC Medicine
BACKGROUND: Achieving adequate antimalarial drug exposure is essential for curing malaria. Day 7 blood or plasma lumefantrine concentrations provide a simple measure of drug exposure that correlates well with artemether-lumefantrine efficacy. However
Autor:
Gwenaelle Carn, Eric Comte, Elizabeth A. Ashley, Elisabeth Baudin, Richard G. Smith, Loretxu Pinoges, Yah Zolia, Vincent Jullien, Michel Branger, Joel J. Jones, Birgit Schramm, Jean-René Kiechel, Charles S Mazinda, Arnaud Bruneel, Philippe J Guerin, Parastou Valeh, Timothy Sundaygar
Publikováno v:
Malaria Journal
Malaria Journal, BioMed Central, 2013, 12 (1), pp.250. ⟨10.1186/1475-2875-12-250⟩
Malaria Journal, 2013, 12 (1), pp.250. ⟨10.1186/1475-2875-12-250⟩
Malaria Journal, BioMed Central, 2013, 12 (1), pp.250. 〈10.1186/1475-2875-12-250〉
Malaria Journal, BioMed Central, 2013, 12 (1), pp.250. ⟨10.1186/1475-2875-12-250⟩
Malaria Journal, 2013, 12 (1), pp.250. ⟨10.1186/1475-2875-12-250⟩
Malaria Journal, BioMed Central, 2013, 12 (1), pp.250. 〈10.1186/1475-2875-12-250〉
Safety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in the over five years age group are largely anecdotal. Two open-label, randomized trials were conducted in Nimba County, Liberia: i) t